GlassScriptPhysician profile
Kennetha Alvarez
NPI 1417511353
$1,246.96
in general payments reported to CMS, 2019-2025
12 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.58 · 2022: $363 · 2023: $183 · 2024: $142 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $176.14 | 2022-2023 | Repatha |
| Gilead Sciences, INC. | $171.07 | 2021-2025 | Livdelzi |
| Axsome Therapeutics, INC. | $149.22 | 2025 | Symbravo |
| Abbvie INC. | $144.61 | 2022-2023 | |
| Stryker Corporation | $117.36 | 2023-2024 | Infinity Adaptis, Mako |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.34 | 2024-2025 | Lifevest |
| Esperion Therapeutics, INC. | $104.02 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.07 | 2022 | |
| Corcept Therapeutics | $80.16 | 2025 | Korlym |
| Genzyme Corporation | $66.16 | 2025 | |
| Kestra Medical Technology Services, INC. | $22.31 | 2025 | Assure Wcd |
| Tactile Systems Technology INC | $21.50 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kennetha Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.